“We’ve got to look at the analyses, the real granular data. It’s always tough when you’re looking at a press release to figure out what’s going on.”

Chris Arderne writes: Surprised to see you hadn’t yet discussed the Oxford/AstraZeneca 60%/90% story on the blog. They accidentally changed the dose for some patients without an hypothesis, saw that it worked out better and are now (sort of) claiming 90% as a result… Sounds like your kind of investigation? I hadn’t heard about this …